Featured Research

from universities, journals, and other organizations

Sperm Injection: Male-factor Infertility Technique Surging

Date:
July 20, 2007
Source:
University of Illinois at Chicago
Summary:
A national study reveals that intracytoplasmic sperm injection, an assisted reproductive technology used to treat male-factor infertility, has increased dramatically in the United States since 1995 while the proportion of patients receiving treatment for male-factor infertility has remained stable.

Rendering of a spermatozoon.
Credit: iStockphoto/Alexander Kozachok

A national study reveals that the use of intracytoplasmic sperm injection or ICSI -- an assisted reproductive technology used to treat male-factor infertility -- has increased dramatically in the United States since 1995, while the proportion of patients receiving treatment for male-factor infertility has remained stable.

"Despite its added cost and uncertain efficacy and risk, the use of ICSI has been extended to include patients without documented male-factor infertility," said Dr. Tarun Jain, assistant professor of reproductive endocrinology and infertility at the University of Illinois at Chicago and lead author of the study that appears in the July 19 issue of the New England Journal of Medicine.

The research also compared the use of ICSI in states with and without mandated insurance coverage for infertility treatment.

States with mandated insurance coverage for infertility (Illinois, Massachusetts and Rhode Island) had a greater use of ICSI for reasons other than male-factor infertility when compared to states without mandated insurance coverage.

The researchers analyzed national data on assisted reproductive technology during a 10-year time span from 1995 to 2004. The study included all in vitro fertilization cycles involving fresh embryos from non-donor eggs in women younger than 43.

"The percentage of IVF cycles that used ICSI increased dramatically during the 10-year time span, from 11 percent to 57.5 percent, while the percentage of diagnosis for male-factor infertility remained steady," said Jain.

They also found that the number of fertility clinics and the number of fresh-embryo cycles has increased, as have pregnancy and live-birth rates.

Jain notes that some physicians may feel ICSI is appropriate for patients who have failed prior IVF cycles, for patients who have very few eggs available, or to overcome barriers to the normal fertilization process.

The largest study to compare traditional IVF with ICSI in patients without male-factor infertility found that patients who underwent ICSI had lower rates of implantation and pregnancy than patients who did not have ICSI, according to Jain.

There have been very few studies to evaluate the routine use of ICSI and the possibility of associated risks, such as genetic disorders and congenital anomalies.

"Further studies are needed to better understand the proper role of ICSI, and perhaps guidelines may be useful to determine what the best indications are for use of the technology in patients without male-factor infertility," said Jain.

Ruchi Gupta of Northwestern University is co-author of the study.


Story Source:

The above story is based on materials provided by University of Illinois at Chicago. Note: Materials may be edited for content and length.


Cite This Page:

University of Illinois at Chicago. "Sperm Injection: Male-factor Infertility Technique Surging." ScienceDaily. ScienceDaily, 20 July 2007. <www.sciencedaily.com/releases/2007/07/070719011244.htm>.
University of Illinois at Chicago. (2007, July 20). Sperm Injection: Male-factor Infertility Technique Surging. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2007/07/070719011244.htm
University of Illinois at Chicago. "Sperm Injection: Male-factor Infertility Technique Surging." ScienceDaily. www.sciencedaily.com/releases/2007/07/070719011244.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Ebola Virus Threatens West Africa

Deadly Ebola Virus Threatens West Africa

AP (July 28, 2014) West African nations and international health organizations are working to contain the largest Ebola outbreak in history. It's one of the deadliest diseases known to man, but the CDC says it's unlikely to spread in the U.S. (July 28) Video provided by AP
Powered by NewsLook.com
$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Two Americans Contract Ebola in Liberia

Two Americans Contract Ebola in Liberia

Reuters - US Online Video (July 28, 2014) Two American aid workers in Liberia test positive for Ebola while working to combat the deadliest outbreak of the virus ever. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins